loadpatents
Patent applications and USPTO patent grants for KANKANALA; Jayakanth.The latest application filed is for "heterocyclic compounds as adenosine antagonists".
Patent | Date |
---|---|
Heterocyclic Compounds As Adenosine Antagonists App 20220298142 - PHAM; Son Minh ;   et al. | 2022-09-22 |
Heterocyclic Compounds As Kinase Inhibitors App 20220281859 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-09-08 |
Heterocyclic Compounds As Kinase Inhibitors App 20220273659 - PHAM; Son Minh ;   et al. | 2022-09-01 |
Heterocyclic Compounds And Uses Thereof App 20220220115 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-07-14 |
Substituted 1,6-dihydropyridinones And 1,2-dihydroisoquinolinones As Bet Inhibitors App 20220213122 - PHAM; Son Minh ;   et al. | 2022-07-07 |
Heterocyclic Compounds And Uses Thereof App 20220169646 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-06-02 |
1,8-naphthyridinone Compounds And Uses Thereof App 20220169648 - PHAM; Son Minh ;   et al. | 2022-06-02 |
Heterocyclic Compounds And Uses Thereof App 20220168313 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-06-02 |
Heterocyclic Compounds And Uses Thereof App 20220162229 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-05-26 |
Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitors Grant 11,332,473 - Chakravarty , et al. May 17, 2 | 2022-05-17 |
Heterocyclic Compounds As Adenosine Antagonists App 20220119367 - PHAM; Son Minh ;   et al. | 2022-04-21 |
Heterocyclic compounds as adenosine antagonists Grant 11,306,071 - Pham , et al. April 19, 2 | 2022-04-19 |
Heterocyclic compounds and uses thereof Grant 11,299,493 - Chakravarty , et al. April 12, 2 | 2022-04-12 |
Diarylhydantoin compounds and methods of use thereof Grant 11,292,782 - Chakravarty , et al. April 5, 2 | 2022-04-05 |
1,8-naphthyridinone compounds and uses thereof Grant 11,254,670 - Pham , et al. February 22, 2 | 2022-02-22 |
Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors Grant 11,192,900 - Pham , et al. December 7, 2 | 2021-12-07 |
Heterocyclic compounds as kinase inhibitors Grant 11,174,252 - Pham , et al. November 16, 2 | 2021-11-16 |
Anti-cancer Nuclear Hormone Receptor-targeting Compounds App 20210214316 - Pham; Son Minh ;   et al. | 2021-07-15 |
Pyrrole and pyrazole compounds and methods of use thereof Grant 11,034,669 - Chakravarty , et al. June 15, 2 | 2021-06-15 |
Heterocyclic Compounds As Bet Inhibitors App 20210002293 - PHAM; Son Minh ;   et al. | 2021-01-07 |
Anti-cancer Nuclear Hormone Receptor-targeting Compounds App 20200360523 - Hung; David ;   et al. | 2020-11-19 |
Heterocyclic compounds and uses thereof Grant 10,807,994 - Chakravarty , et al. October 20, 2 | 2020-10-20 |
Heterocyclic Compounds And Uses Thereof App 20200325142 - CHAKRAVARTY; Sarvajit ;   et al. | 2020-10-15 |
Pyrrole And Pyrazole Compounds And Methods Of Use Thereof App 20200239433 - Chakravarty; Sarvajit ;   et al. | 2020-07-30 |
Heterocyclic Compounds As Adenosine Antagonists App 20200231570 - PHAM; Son Minh ;   et al. | 2020-07-23 |
1,8-naphthyridinone Compounds And Uses Thereof App 20200231589 - PHAM; Son Minh ;   et al. | 2020-07-23 |
Diarylhydantoin Compounds And Methods Of Use Thereof App 20200199098 - Chakravarty; Sarvajit ;   et al. | 2020-06-25 |
Heterocyclic Compounds As Bet Inhibitors App 20200140459 - PHAM; Son Minh ;   et al. | 2020-05-07 |
Compounds for cancer chemotherapeutic sensitization Grant 10,617,706 - Wang , et al. | 2020-04-14 |
Anti-cancer Nuclear Hormone Receptor-targeting Compounds App 20190375732 - Hung; David ;   et al. | 2019-12-12 |
Heterocyclic Compounds As Kinase Inhibitors App 20190248774 - PHAM; Son Minh ;   et al. | 2019-08-15 |
Compounds For Cancer Chemotherapeutic Sensitization App 20190240244 - Wang; Zhengqiang ;   et al. | 2019-08-08 |
Heterocyclic Compounds And Uses Thereof App 20190106436 - Chakravarty; Sarvajit ;   et al. | 2019-04-11 |
Heterocyclic Compounds And Uses Thereof App 20190106427 - Chakravarty; Sarvajit ;   et al. | 2019-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.